PHK
VKTX icon

Point72 Hong Kong’s Viking Therapeutics VKTX Stock Holding History

Point72 Hong Kong’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-44
Closed – – 2451
2022
Q2 		$0 Sell
44
-22,958
-100% -$56.8K ﹤0.01% 2444
2022
Q1 		$69K Buy
23,002
+14,708
+177% +$52.8K ﹤0.01% 1257
2021
Q4 		$38K Buy
+8,294
New +$46.5K ﹤0.01% 1408
2021
Q1 		– Sell
-2,159
Closed -$12K – 2240
2020
Q4 		$12K Buy
2,159
+513
+31% +$3.11K ﹤0.01% 1513
2020
Q3 		$10K Buy
+1,646
New +$11.3K ﹤0.01% 993
2019
Q3 		– Sell
-2,834
Closed -$24K – 1371
2019
Q2 		$24K Buy
+2,834
New +$24.2K 0.01% 751
2019
Q1 		– Sell
-216
Closed -$2K – 1293
2018
Q4 		$2K Buy
+216
New +$2.58K ﹤0.01% 757
2018
Q3 		– Sell
-7,462
Closed -$71K – 1191
2018
Q2 		$71K Buy
+7,462
New +$49.6K 0.02% 375

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Point72 Hong Kong's VKTX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Viking Therapeutics (VKTX) in Q3 2022, closing a stake of 44 shares.

Point72 Hong Kong first reported a position in VKTX in Q2 2018 and held it in 8 quarters. The position peaked at $71K in Q2 2018. 107 funds tracked by Wall St. Rank hold VKTX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Viking Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 44 Viking Therapeutics shares in Q3 2022.
  • Point72 Hong Kong first reported a position in Viking Therapeutics in Q2 2018 and held it in 8 quarters.
  • Point72 Hong Kong's Viking Therapeutics position peaked at $71K in Q2 2018.
  • 107 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.